Results 141 to 150 of about 83,305 (348)

Consequences of colectomy: pathogenetic damages and correction outlooks

open access: yesБюллетень сибирской медицины, 2003
On the base of experimental and clinical investigations there has been found that continent reservoir ileorectostomies after colectomy under the rectal contents effect had been exposed to degenerative and dysplastic mucous changes. These damages prohibit
S. R. Bashirov
doaj   +1 more source

The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome—A prospective longitudinal study

open access: yesInternational Journal of Cancer, Volume 158, Issue 1, Page 257-266, 1 January 2026.
What's new? Lynch syndrome demands lifelong colonoscopy surveillance to early detect and treat colorectal cancer (CRC) and prevent CRC by removing adenomas. However, colonoscopy overuse and post‐colonoscopy CRC rates among individuals with Lynch syndrome are problematic.
Elsa L. S. A. van Liere   +9 more
wiley   +1 more source

Short‐term outcomes of intracorporeal anastomosis in laparoscopic colectomy for colon cancer: A nationwide, multi‐institutional cohort study in Japan (ICAN study)

open access: yesAnnals of Gastroenterological Surgery
Background Several randomized controlled trials and meta‐analyses have demonstrated the potential advantages of intracorporeal over extracorporeal anastomosis.
Tomohiro Yamaguchi   +18 more
doaj   +1 more source

Mortality risk prediction in octogenarians undergoing emergency colorectal surgery: a tertiary center experience and systematic review of the literature

open access: yesFrontiers in Surgery
ObjectiveSurgical colonic emergencies frequently occur in elderly patients. In these cases a comprehensive preoperative assessment is crucial to tailor surgical invasiveness to individual risk profiles and potentially improve clinical outcomes.
Marco Brolese   +10 more
doaj   +1 more source

Systematic Review: Efficacy, Safety and Metabolic Outcomes of GLP‐1 Receptor Agonists in Inflammatory Bowel Disease

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 1, Page 17-39, January 2026.
GLP‐1 receptor agonists are generally effective in weight loss and improvement in metabolic markers. They are well tolerated in patients with inflammatory bowel disease, with observational evidence showing no increased risk of disease exacerbation and possible signals of reduced steroid use, hospitalization, and surgery. ABSTRACT Background Obesity and
Brooke Maracle   +8 more
wiley   +1 more source

Management of the Rectal Stump after Subtotal Colectomy Operations for Inflammatory Bowel Disease in the Era of Immunologic Therapy: A Two-Centre Cohort Study

open access: hybrid, 2023
Dominika Boldovjáková   +8 more
openalex   +1 more source

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

open access: yesMolecular Oncology, Volume 19, Issue 12, Page 3486-3498, December 2025.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy